{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:30:25Z","timestamp":1782509425510,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RGP-043"],"award-info":[{"award-number":["RGP-043"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jchromb.2020.122125","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:13:07Z","timestamp":1587964387000},"page":"122125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma"],"prefix":"10.1016","volume":"1146","author":[{"given":"Zeid A.","family":"ALOthman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"Alsheetan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Y.","family":"Aboul-Enein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122125_b0005","author":"Global Health Observatory","year":"2012","journal-title":"World Health Organization"},{"key":"10.1016\/j.jchromb.2020.122125_b0010","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0731-7085(95)01575-2","article-title":"A fluorimetric liquid chromatographic method for the determination of propranolol in human serum\/plasma","volume":"13","author":"Rekhi","year":"1995","journal-title":"J. Pharm. & Biomed. Anal."},{"key":"10.1016\/j.jchromb.2020.122125_b0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.talanta.2008.11.043","article-title":"Chiral separation of \u03b2-adrenergic blockers on cellucoat column by HPLC","volume":"78","author":"Ali","year":"2009","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2020.122125_b0020","series-title":"FDA Approves First Generic Versions of Coreg","author":"Release","year":"2007"},{"key":"10.1016\/j.jchromb.2020.122125_b0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.jchromb.2020.122125_b0030","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.01.00086201","article-title":"The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis","volume":"17","author":"Rodgers","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jchromb.2020.122125_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.talanta.2004.06.012","article-title":"Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica column","volume":"65","author":"Aboul-Enein","year":"2004","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2020.122125_b0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15422110802589916","article-title":"Polysaccharides chiral stationary phases in liquid chromatography","volume":"38","author":"Ali","year":"2009","journal-title":"Sep. & Purif. Rev."},{"key":"10.1016\/j.jchromb.2020.122125_b0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/chir.20397","article-title":"Role of racemization in optically active drug development","volume":"19","author":"Ali","year":"2007","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2020.122125_b0050","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jssc.200500372","article-title":"Impact of immobilized polysaccharide chiral stationary phases on enantiomeric separations","volume":"29","author":"Ali","year":"2006","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2020.122125_b0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1573412912666160422130018","article-title":"SPMMTE and HPLC methods for the analyses of cardiovascular drugs in human plasma using new generation C28 column","volume":"13","author":"Ali","year":"2017","journal-title":"Cur. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2020.122125_b0060","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/jssc.200800123","article-title":"Hyphenation in sample preparation: Advancement from micro to nano world","volume":"31","author":"Ali","year":"2008","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2020.122125_b0105","first-page":"11260","article-title":"Validation of Analytical","volume":"60","author":"Federal Register","year":"1995","journal-title":"Procedures"},{"key":"10.1016\/j.jchromb.2020.122125_b0110","first-page":"27463","article-title":"Validation of Analytical Procedures","volume":"62","author":"Federal Register (FDA)","year":"1997","journal-title":"Methodology"},{"key":"10.1016\/j.jchromb.2020.122125_b0115","first-page":"52776","volume":"65","author":"Federal Register (FDA)","year":"2000","journal-title":"Analytical Procedures and Methods Validation: Chemistry, Manufacturing and Controls Documentation"},{"key":"10.1016\/j.jchromb.2020.122125_b0120","article-title":"Validation of Chromatographic Methods","author":"FDA, Reviewer Guidance","year":"1994","journal-title":"Center for Drug Evaluation Research (CDER), Washington, USA"},{"key":"10.1016\/j.jchromb.2020.122125_b0125","unstructured":"FDA, \u201cGuidelines for submitting samples and analytical data for method validation, Rockville, MD.\u201dCenter for Drugs and Biologics Department of Health and Human Services, Washington, USA (1987)."},{"key":"10.1016\/j.jchromb.2020.122125_b0130","unstructured":"USP 25\u2013NF 20, Validation of Compendial Methods Section (1225) (United States Pharmacopeal Convention, Rockville, Maryland, USA (2002) pp. 2256."},{"key":"10.1016\/j.jchromb.2020.122125_b0135","unstructured":"The United State Pharmacopeia (24th Ed.). United States Pharmacopeial Convention, Rockville, MD (2000)."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322030578X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322030578X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:00:03Z","timestamp":1761606003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322030578X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":19,"alternative-id":["S157002322030578X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122125","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122125"}}